Muscle-invasive bladder cancer

被引：1
|
作者：
Buchler, Jakob [1 ]
Gschwend, Juergen E. [1 ]
Retz, Margitta [1 ]
Schmid, Sebastian C. [1 ]
机构：
[1] Tech Univ Munich, Univ Klinikum Rechts Isar, Klin & Poliklin Urol, Ismaninger Str 22, D-81675 Munich, Germany
来源：
UROLOGE | 2021年 / 60卷 / 06期
关键词：
Urinary bladder neoplasms; Transurethral resection; BCG; Cystectomy; Chemotherapy; neoadjuvant; Urinary division; BACILLUS-CALMETTE-GUERIN; TRANSURETHRAL RESECTION; RADICAL CYSTECTOMY; ILEAL CONDUIT; FLUORESCENCE CYSTOSCOPY; UROTHELIAL CARCINOMA; RECURRENCE; T1; METAANALYSIS; PROGRESSION;
D O I：
10.1007/s00120-021-01536-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Bladder cancer, which is a complex disease, can be treated with a variety of stage-oriented treatment options. In this article, the treatment recommendations of the German S3 guideline "Early detection, diagnosis, treatment and aftercare of bladder cancer" are applied in a fictitious case study. In a patient with invasive transitional cell carcinoma, the treatment options-ranging from bladder preservation to radical cystectomy with neoadjuvant chemotherapy-are discussed on the basis of the current literature.
引用
收藏
页码：769 / 775
页数：7
相关论文
共 50 条
  • [21] Sensitivity to chemoradiation predicts development of metastasis in muscle-invasive bladder cancer patients
    Koga, Fumitaka
    Numao, Noboru
    Saito, Kazutaka
    Masuda, Hitoshi
    Fujii, Yasuhisa
    Kawakami, Satoru
    Kihara, Kazunori
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (07) : 1270 - 1275
  • [22] Surgical bladder-preserving techniques in the management of muscle-invasive bladder cancer
    Lyons, Matthew D.
    Smith, Angela B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (06) : 262 - 270
  • [23] Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer
    Clark, Peter E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 821 - 830
  • [24] Chemoradiation for organ preservation in the treatment of muscle-invasive bladder cancer
    McHaffie, Derek R.
    Kruser, Tim J.
    Gaston, Kris
    Mahoney, John
    Graham, David
    Haake, Michael
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (06) : 271 - 278
  • [25] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
    Johnson, Skyler B.
    Yu, James B.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (09)
  • [26] Chemotherapy for Muscle-Invasive Bladder Cancer
    Trenta, Patrizia
    Calabro, Fabio
    Cerbone, Linda
    Sternberg, Cora N.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2016, 17 (01) : 1 - 14
  • [27] Predictors of Outcome of Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer
    Youssef, Ramy F.
    Lotan, Yair
    THESCIENTIFICWORLDJOURNAL, 2011, 11 : 369 - 381
  • [28] Treatment of muscle-invasive and advanced bladder cancer in 2020
    Patel, Vaibhav G.
    Oh, William K.
    Galsky, Matthew D.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2020, 70 (05) : 404 - 423
  • [29] Diagnostics and surgical treatment of muscle-invasive bladder cancer
    Niegisch, G.
    Kuebler, H.
    Gschwend, J. E.
    Heck, M.
    ONKOLOGE, 2018, 24 (01): : 32 - 39
  • [30] Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer
    Harshman, Lauren C.
    Tripathi, Abhishek
    Kaag, Matthew
    Efstathiou, Jason A.
    Apolo, Andrea B.
    Hoffman-Censits, Jean H.
    Stadler, Walter M.
    Yu, Evan Y.
    Bochner, Bernard H.
    Skinner, Eila C.
    Downs, Tracy
    Kiltie, Anne E.
    Bajorin, Dean F.
    Guru, Khurshid
    Shipley, William U.
    Steinberg, Gary D.
    Hahn, Noah M.
    Sridhar, Srikala S.
    CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : 213 - 218
12345